Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia
, , , , , , , , and | Apr 06, 2020
About this article
Article Category: Original scientific article
Published Online: Apr 06, 2020
Page range: 83 - 91
Received: Sep 02, 2019
Accepted: Feb 13, 2020
DOI: https://doi.org/10.2478/sjph-2020-0011
Keywords
© 2020 Đurđa Vukićević et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Đurđa Vukićević
UMIT - University for Health Sciences, Medical Informatics and Technology,
Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTAAustria
Ursula Rochau
UMIT - University for Health Sciences, Medical Informatics and Technology,
Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTAAustria
Aleksandar Savić
University of Novi Sad,
Faculty of Medicine, Clinical Center of Vojvodina, Clinic for HematologySerbia
Monika Schaffner
UMIT - University for Health Sciences, Medical Informatics and Technology,
Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTAAustria
Milica Jevđević
UMIT - University for Health Sciences, Medical Informatics and Technology,
Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTAAustria
Igor Stojkov
UMIT - University for Health Sciences, Medical Informatics and Technology,
Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTAAustria
Gaby Sroczynski
UMIT - University for Health Sciences, Medical Informatics and Technology,
Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTAAustria
Wolfgang Willenbacher
Medical University,
Internal Medicine V, Hematology and OncologyInnsbruck, Austria
Beate Jahn
UMIT - University for Health Sciences, Medical Informatics and Technology,
Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTAAustria
Uwe Siebert
Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL - Center for Personalized Cancer Medicine,
Innsbruck, Austria
Harvard Chan School of Public Health,
Boston
Massachusetts General Hospital, Institute for Technology Assessment and Department of Radiology,